TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Fluctuation of ascorbic acid plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disability days reported
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: injury report filing
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of leg cramps per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of C. trachomatis and N. gonorrhoeae infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Systolic arterial pressure increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain intensity when coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hypaesthetic dermatomal segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentration of fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive concerns reduction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Functional goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Decreased exercise SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased Vo(2)peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral density at the spine and total hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: No evidence of either progression or inflammatory disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of cardiac toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean absolute LVEF reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: S100B protein level in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean arterial flow velocity of distal parent vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Command response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire for additional cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in high-density lipoprotein cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in HOMA-IR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in FAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average time to complete trials of the TOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: prevalence of obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: demand for calories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal recognition of the fetus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of mean weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean peak particle diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: number of local recurrences
Endpoint domain: Mortality/survival
Primary endpoint: Students felt better prepared for the practical course
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Log10(Volume) of the primary tumor and lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering of fasting and 2-hour plasma glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in β-cell function (ΔC-Pep0-120/ΔG0-120 ÷ insulin resistance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in whole-body insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: perioperative pathways duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: satisfaction about final visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: positive experiences with counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived personal control 1 year post-counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improved mental health functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fewer drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-8) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of developing adverse systemic effects
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of alveolar inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: loneliness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: perceived social support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: computer self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NEFA suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Impact on mother's relationships
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to cessation of severe pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall success rate of direct pulp capping
Endpoint domain: Mortality/survival
Primary endpoint: CSF 5‐HIAA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perivascular adiponectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ED50 of first twitch recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED80 of first twitch recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED50 of TOF ratio recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Mass (LVM) regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recurrence of atrial arrhythmias
Endpoint domain: Mortality/survival
Primary endpoint: Nursing home placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in papules/pustules on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Satisfactory improvement of moderate acne
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete resolution of moderate acne
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asthma severity score (ASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrement of VEF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ovulatory dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Peak knee extension and adduction moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Loading rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean percentage decrease in clinical severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global improvement rated by patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ability to do a full day's work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prevention of PPH after C-section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time from symptom onset to first medical contact
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median door-to-balloon time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete response (CR) in the neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: median progression-free interval
Endpoint domain: Mortality/survival
Primary endpoint: Influenza confirmed by RT-PCR
Endpoint domain: Mortality/survival
Primary endpoint: Binary angiographic restenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of syncope recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of negative response in HUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS relapses
Endpoint domain: Mortality/survival
Primary endpoint: Aortic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Aortic stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Removal of dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: white matter changes grade 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of quitting job
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: bond strength values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Increased 24-hour postoperative CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP usage hours per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP usage percentage of possible nights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood to continue using CPAP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of fungal infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: success rate for cholangiopancreatography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned visits for asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Artifact size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scanning time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: LDL particle concentration <1,000 nmol/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL cholesterol <2.59 mmol/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative systemic arterial ET levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary artery pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in HCV RNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: marital functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: experience of caregiver empathic care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Non-HDL cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: β2 microglobulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cystatin C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death due to IA
Endpoint domain: Mortality/survival
Primary endpoint: Diuretic effect (urinary volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Penile tip rigidity on RigiScan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for homologous blood transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of induction of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in walking speed (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered in 6 minutes (6mWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived positive impact of OEAGT (TAM questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dyspnoea-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful postdischarge contact rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to study products during all sex acts
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Manometric relaxation achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom improvement in straining index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction with Botox injection results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PANSS excited component score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total:LDL and LDL:HDL ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid and lipoprotein outcomes
Primary endpoint: plasma HDL cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid and lipoprotein outcomes
Primary endpoint: Systolic and diastolic blood pressure percentiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to complete resolution of cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough severity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of TC and LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum levels of TG and HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum levels of ApoA(1) and ApoB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum TRAb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucagon concentration at nadir plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients experiencing at least 1 treatment-related adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of discontinuation due to treatment-associated AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of treatment-associated myalgia
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: FPG levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in acetazolamide reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: donor return rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimate of likelihood to give blood again
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caecal intubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adequacy of nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant-reported pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recidives of uterine fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tlim
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: exercise IC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Withdrawal rates due to adverse events/lack of efficacy
Endpoint domain: Adverse events/effects
Primary endpoint: Level of agreement (adjusted kappa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F1 + 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Daily spontaneous physical activity energy expenditure (PAEE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg and arm strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified total Sharp score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: clinical remission (Disease Activity Score 28‐joint count < 2.6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: serious infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Low Birth Weight (LBW) births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: LRC (Local Recurrence Rate)
Endpoint domain: Mortality/survival
Primary endpoint: NPRS(flight) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MODI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GRCS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity of Quick-view algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-4 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax0-4 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who delivered within 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total misoprostol dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in concentrations of serum folate, vitamin B‐1, vitamin B‐2, vitamin B‐12, 25‐hydroxyvitamin D, and plasma zinc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of folate, vitamin B‐12, and vitamin D deficiencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Activities of serum GSH‐Px and plasma SOD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DRSS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in peak VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission (DAS28CRP less than 2.6) after 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lesion rehardening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: watery faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: total bowel movement frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bone mineral density at the total hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Behavioral Assessment Scale (NBAS) Indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Infant Pain Scale (NIPS) Indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuropsychological test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes